GLENMARK PHARMACEUTICALS LTD.

Company Overview

Glenmark Pharmaceuticals Ltd. is an India-based pharmaceutical company. The company operates in three businesses, which include drug discovery, formulation business and Glenmark Generics Ltd., a subsidiary of the company. The company’s drug discovery is focused on the areas of inflammation, metabolic disorders and pain.

The company’s formulations business focuses on therapeutic areas, including dermatology, anti-infectives, respiratory, cardiac, diabetes, gynecology, central nervous system and oncology. Its GGL’s businesses focus on segments, including dermatology, hormones, controlled substances, oncology and modified release products. The company’s research pipeline includes GRC 5XXXXX, GRC 17536, GRC 27864, GBR 1302 and GBR 1342. It has approximately 16 manufacturing facilities in four countries and has six research and development centers. The research and development focus includes developing new and innovative antifungal products.

Financial Highlights (FY 2024)

Company's Business Segments

• Pharmaceuticals : The company offers a broad range of pharmaceutical products, focusing on research, development, manufacturing of branded, generic, and over-the-counter (OTC) drugs, with a global presence and key therapeutic areas including dermatology, respiratory, and oncology.